市场调查报告书
商品编码
1287293
心电图压力测试市场 - 按产品类型(运动测试系统、压力血压计、压力心电图、脉搏血氧仪),按最终用途(医院、诊断中心、非住院手术中心),及预测,2023 - 2032年ECG Stress Test Market - By Product Type (Exercise Testing Systems, Stress Blood Pressure Monitors, Stress ECG, Pulse Oximeters), By End-use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), & Forecast, 2023 - 2032 |
到2032年,全球心电图压力测试市场规模将大幅扩大。老年人口的增长和老龄人对心血管疾病(如中风、心脏骤停等)的高敏感度,增加了对心电图压力测试的需求。根据世界卫生组织的数据,到2030年,全球每6个人中就有1个是60岁及以上的人。
该领域的行业竞争者正在强调合併和收购战略,以扩大其足迹。例如,2022年7月,美国跨国医疗技术公司Becton Dickinson and Co.完成了对Parata Systems的收购,后者是药房自动化组合领域的领导者。这次收购将帮助该公司提供智能和互联护理技术。
整个心电图压力测试市场根据产品、终端用途和地区进行分类。
就产品而言,应激式血压计的市场价值将在2032年之前积累大量收益。这些监测器的高精确度增加了它们的采用。此外,全球心血管疾病发病率的上升进一步增加了对这些监测器的需求。根据CDC的数据,仅在美国,每年就有超过79.5万人被诊断出中风。应激式血压计已经经历了几次升级,现在拥有先进的功能。
对于患有高血压或其他心血管疾病的人来说,压力血压计有助于评估药物治疗或生活方式干预的有效性。它有助于确定是否存在高血压、低血压或不规则血压波动等情况。
就终端用途而言,非住院手术中心部分的心电图压力测试市场规模到2032年将明显扩大。这些设施对心血管疾病的高成本效益的治疗方案的可用性,促进了该部分的扩张。这些设施是为门诊手术设计的,这意味着它们可以提供比医院更快和更有效的服务。它们还配备了最先进的工具来进行准确的疾病诊断。
在区域方面,从2023年到2032年,亚太地区心电图压力测试的市场份额将以显著的复合年增长率增长。心血管疾病的高发病率增加了该地区对心电图压力测试的需求。此外,随着人口迅速老龄化,政府对医疗保健部门的有利支持,也进一步积极影响了该地区的前景。几个区域经济体的政府也在对医疗设备部门进行大量投资,这可能有助于为该区域的行业开辟一条健康的增长轨迹。
Global ECG Stress Test Market size will expand substantially through 2032. Growing geriatric population and the higher susceptibility of aging people to cardiovascular diseases such as stroke, cardiac arrest, and others have increased the need for ECG stress tests. As per the WHO, 1 in every 6 people across the globe will be 60 years and above by 2030.
Industry contenders in this field are emphasizing mergers and acquisition strategies to extend their footprint. For instance, in July 2022, Becton Dickinson and Co., an American multinational medical technology company, completed the acquisition of Parata Systems, a leader in the pharmacy automation portfolio space. This acquisition will help the company deliver smart and connected care technologies.
The overall ECG stress test market is classified based on product, end-use, and region.
In terms of product, stress blood pressure monitors market value will amass substantial gains through 2032. High accuracy of these monitors has increased their adoption. Moreover, the rising prevalence of cardiovascular disorders globally has further increased the need for these monitors. As per the CDC, stroke is diagnosed in over 795,000 people every year in the U.S. alone. Stress blood pressure monitors have undergone several upgrades and now boast advanced features.
For individuals with hypertension or other cardiovascular conditions, stress blood pressure monitors help evaluate the effectiveness of medication or lifestyle interventions. It helps determine the presence of conditions such as hypertension, hypotension, or irregular blood pressure fluctuations.
With respect to end-use, the ECG stress test market size from the ambulatory surgical centers segment will expand notably through 2032. High availability of cost-effective treatment solutions in these facilities for cardiovascular disorders is contributing to segment expansion. These facilities are designed for outpatient procedures, implying they can provide faster and more efficient services than hospitals. They are also equipped with cutting-edge tools for accurate disease diagnosis.
On the regional front, the Asia Pacific ECG stress test market share will grow at a significant CAGR from 2023 to 2032. High incidence rate of cardiovascular disorders has increased the demand for ECG stress tests in the region. Moreover, favorable government support towards the healthcare sector, in line with a rapidly aging population, is further positively affecting the regional outlook. Governments across several regional economies are also investing significantly in the medical device sector, which may help carve a healthy growth trajectory for the regional industry.